Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monitoring the effect of oral anticoagulants during percutaneous coronary intervention
2020-005298-29Phase 4Completed
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Mar 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of heparin (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Laboratory measurements. Started Mar 2021; status: completed.
02
Drugs
heparin
Beyond the preview
Go deeper on 2020-005298-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005298-29.